Carl Schoellhammer retweeted
Our CEO, @Ori_JCFoster, spoke to Carl Schoellhammer (@CMBS6) from @DeciBio to explore the evolution of the #celltherapy sector and how innovative technologies are shaping #PatientAccess to these life changing therapies.
Read more: decibio.com/insights/ori-bio…
Carl Schoellhammer retweeted
This Giving Tuesday, consider helping baby Lucas!
His parents @AdaLio924 and @Nathan_YG are working with world class scientists on drug dev for his ultra-rare disease, ZTTK. They have a comprehensive plan to put this money to work to accelerate research:
tinyurl.com/4m5xa239
Looking forward to connecting with friends new and old at #ASGCT23
Hot off the press in time for attending #ASGCT23. We updated our manufacturing landscape for #celltherapy
Read more about it on our website: lnkd.in/g68rptxg
#cellmanufacturing #biotechnews #celltherapy #therapeutics #drugdiscovery #precisionmedicine
got to chat #siRNA and #oligos with @juneatsirnagen Want to see where the #therapeutics field will go? have a read and find out!
#strategyconsulting #therapeutics #genetherapy
decibio.com/insights/the-bro…
Making #RNA #medicines more broadly applicable will take new #delivery technologies. @SuonoBio 's platform for formulation-agnostic delivery of #oligos may do just that!
businesswire.com/news/home/2…
Official #predictions2022 for the #cellandgenetherapy field. Have a look and let us know what you think will happen #biotech #celltherapy #genetherapy #oligonucleotides decibio.com/insights/2022-ce…
Carl Schoellhammer retweeted
10 out of 10 recommend listening to this podcast of @SuonoBio's journey from the lab to the marketplace, an excellent example of how ideas get shaped into impactful #innovations.
Listen here apple.co/3iP7G6D
@CMBS6 @MIT_Innovation @MIT
Great writeup by @ZachinBoston @MIT on the power of #ultrasound for #drugdelivery and how @SuonoBio might enable the use of #nucleicacids and #DNA and #RNA drugs more broadly. #IBD
news.mit.edu/2021/suono-bio-…
Had the pleasure to speak with @MaxFinder of @BountifulWork about #entrepreneurship, #biotech #startups , and what @SuonoBio is up to. Have a listen!
Make sure to talk to industry. And just GRIND. Wisdom for young researchers and entrepreneurs from the founder of @suonobio, a spinout from the great @LangerLab and @enginexyz portfolio company, using ultrasound to deliver drugs through skin. Congrats on raising the series A!
Congrats to partners @ktrae, @reedsturtevant and Ann DeWitt for making the list. The TC List represents investors who have demonstrated a commitment to writing first checks and leading rounds from seed through growth. #toughtech #vc #startups
Very cool program for #healthtech #startups out of @RosenmanInst offering #funding, #mentorship, and other support. Deadline to apply is July 6. #founders don't delay!!
rosenmaninstitute.org/adapt
Carl Schoellhammer retweeted
Thrilled to announce our new #partner to advance our portfolio of treatments for #IBD towards the #clinic businesswire.com/news/home/2…
Carl Schoellhammer retweeted
“In the 3 years since its inception, The Engine has bridged the gap between ‘tough tech’ companies and venture capital with remarkable success.” Great profile by @MIT News @ZachinBoston, interviewing @ktrae @cambridgecrops @CFS_energy @isee_ai news.mit.edu/2019/the-engine… #ToughTech
Carl Schoellhammer retweeted
Last year, we launched The Engine’s 1st Tough Tech Summit, convening changemakers igniting the Tough Tech movement. Excited to continue the dialogue @ our 2nd annual Tough Tech Summit (Oct 21-22)! Follow #ToughTech @enginexyz this week to learn what’s next for Tough Tech.
New perspective on #zolgensma issue and broader impacts for #biopharma, #drugdevelopment, and #genetherapy @DeciBio
decibio.com/2019/10/02/zolge…
Very proud of the team for our first publication in @JCRnEDITORS with #artwork by @GraphicAnja and many thanks to collaborators @cgtraverso , #RobertLanger @MITChemE @kochinstitute and #JoeLennerz, @MassGeneralNews
Our first #publication! #oraldelivery of macromolecules and treatment of #mucositis using #ultrasound. Great work with collaborators at @kochinstitute and #pathology at @MassGeneralNews sciencedirect.com/science/ar…
New investor in @FujifilmUS, additions to @SuonoBio #leadership #team, and @Xconomy #XconomyAwards all in one day! Busy day! #biotech #BiotechWeekBoston @BiotechWkBoston
Carl Schoellhammer retweeted
We are #hiring! Work in the heart of #biotech in Kendall Square @kendallnow suonobio.com/associate-scien…
Attending @CRSScience #CRSNYC ? Check out @cgtraverso 's talk on #ultrasound technologies during the #oral #peptide pre-meeting workshop Sunday! Rumor is he's even giving a #teaser to some #unpublished #data 😱😱












